Impact of Long-Acting HIV Prevention Drugs

Video

A panel of experts discuss the role of PrEP in HIV prevention with a focus on current and newly approved options.

Related Videos
Video 6 - "Stakeholder Perspective: Step-Up Dosing for Bispecific Antibodies in Multiple Myeloma"
Video 5 - "The Importance of Engaging Stakeholders When Implementing Bispecific Antibodies"
Video 4 - "Risk Evaluation Mitigation Strategy (REMS) Program Requirements for Bispecific Antibodies"
Video 3 - "Monitoring and Treating Adverse Events in Patients Receiving Treatment With a Bispecific Antibody"
Video 2 - "Key Considerations in Treatment Selection for Patients With Multiple Myeloma"
Video 1 - "Impact of Bispecific Antibodies on Multiple Myeloma Treatment"
Pharmacist preparing high-risk chemotherapy
Image Credit: © jarun011 - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.